COVID-19-associated brief psychotic disorder.
Repository Usage Stats
A 36-year-old previously healthy woman with no personal or family history of mental illness presented with new-onset psychosis after a diagnosis of symptomatic COVID-19. Her psychotic symptoms initially improved with antipsychotics and benzodiazepines and further improved with resolution of COVID-19 symptoms. This is the first case of COVID-19-associated psychosis in a patient with no personal or family history of a severe mood or psychotic disorder presenting with symptomatic COVID-19, highlighting the need for vigilant monitoring of neuropsychiatric symptoms in these individuals.
Published Version (Please cite this version)
Smith, Colin M, Jonathan R Komisar, Ahmad Mourad and Brian R Kincaid (2020). COVID-19-associated brief psychotic disorder. BMJ case reports, 13(8). pp. e236940–e236940. 10.1136/bcr-2020-236940 Retrieved from https://hdl.handle.net/10161/23592.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
My primary interest is in the clinical care of people with both medical and psychiatric disorders, particularly in the interactions between mental illness, physical illness, and medications.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.